Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

cisplatin

  • You have access
    Combined Treatment of Cisplatin With Caffeic Acid Phenethyl Ester Demonstrates Additive Growth Inhibition on Non-small Cell Lung Cancer Cells
    CHING-YI LEE, YU-KE FU, CHIEN-CHIH YEH, LI-KUO KUO, YING-YU KUO, CHIEH HUO, SHIH-WEI LEE, YUNG-CHIA HUANG, LI-JANE SHIH, CHIA-YANG LI, SHU-PIN HUANG, CHIH-JEN LAI and CHIH-PIN CHUU
    Anticancer Research November 2025, 45 (11) 4971-4986; DOI: https://doi.org/10.21873/anticanres.17840
  • You have access
    Efficacy of SGLT-2 Inhibitors in Preventing Cisplatin-induced Kidney Injury in Patients With Diabetes
    YUSUKE ISHIGAMI, MASAYA TAKAHASHI, HITOMI NAKATSUKASA, HIRONOBU NISHIURA, YUYA KOHARA and YASUTAKA NAKAMURA
    Anticancer Research November 2025, 45 (11) 5185-5190; DOI: https://doi.org/10.21873/anticanres.17858
  • Open Access
    Comparative Antitumor Efficacy and Toxicity Profile of SCC5, An Ag(I) N-Heterocyclic Carbene Complex, Relative to Platinum-based Chemotherapeutics
    JOSEPH A. BAUER, ANNETTE M. SYSEL and MICHAEL J. DUNPHY
    Anticancer Research September 2025, 45 (9) 3629-3637; DOI: https://doi.org/10.21873/anticanres.17727
  • You have access
    Antioxidant Effects of Bidens Pilosa Extract Protect RAW 264.7 Cells from Cisplatin-induced Cytotoxicity
    KIHIRO SHIMIZU, AKO KUDO, TOKO IIDA, KEISUKE SATO, AKIFUMI NAKATA, KENICHI KOMATU, KAZUKI TAKAI and KOJI WAKAME
    Anticancer Research August 2025, 45 (8) 3459-3467; DOI: https://doi.org/10.21873/anticanres.17707
  • You have access
    Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Enhance Cisplatin-induced Apoptotic Effects via the ROS-Fas Pathway in Human NPC-TW01 Nasopharyngeal Carcinoma Cells
    YINGXIAO LI, BU-MIIN HUANG, CHIH-CHIEH TAO and YU-YAN LAN
    Anticancer Research July 2025, 45 (7) 3117-3126; DOI: https://doi.org/10.21873/anticanres.17675
  • You have access
    Inhibition of Epithelial–Mesenchymal Transition and Migration in Cisplatin-resistant Cancer Through Combined Treatment With Cisplatin and SH003
    HYEONG SIM CHOI, JEONG-KUI KU, SEONG-GYU KO and PIL-YOUNG YUN
    Anticancer Research October 2024, 44 (10) 4359-4369; DOI: https://doi.org/10.21873/anticanres.17265
  • You have access
    Effect of Ganoderma lucidum on Cisplatin-induced Nephrotoxicity and Gastrointestinal Toxicity
    NATSUKI OTA, SHOYA ENDO, RYOSUKE TATSUNAMI, AOI YAMAGUCHI, KOJI WAKAME, AKIFUMI NAKATA and KEISUKE SATO
    Anticancer Research August 2024, 44 (8) 3605-3613; DOI: https://doi.org/10.21873/anticanres.17183
  • Open Access
    The Novel Platinum Analog Dicycloplatin Provides Reliable Growth Inhibition of Urothelial Carcinoma Cells In Vitro
    DAVID ZEKAN, THOMAS HOGAN, BARBARA JACKSON, GARRETT JACKSON and STANLEY KANDZARI
    Anticancer Research August 2024, 44 (8) 3243-3254; DOI: https://doi.org/10.21873/anticanres.17142
  • You have access
    Assessment of Therapeutic Effects of Combined Treatment With Cisplatin and Anti-mouse Programmed Death (PD)-1 Antibody in a Mouse Urothelial Cancer Model
    RYO SATO, KYOHEI WATANABE, YUTO MATSUSHITA, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, ATSUSHI OTSUKA and HIDEAKI MIYAKE
    Anticancer Research April 2024, 44 (4) 1417-1423; DOI: https://doi.org/10.21873/anticanres.16938
  • You have access
    Safety and Efficacy of Gemcitabine Plus Cisplatin Against Recurrent/Metastatic Nasopharyngeal Carcinoma: A Retrospective Study
    HIROYUKI KODAMA, SHIGENORI KADOWAKI, TAIKO NAKAZAWA, YUKI MATSUBARA, YUKIYA NARITA, KAZUNORI HONDA, TOSHIKI MASUISHI, HIROYA TANIGUCHI, MASASHI ANDO, YUTARO KOIDE, HIROYUKI TACHIBANA, TAKESHI KODAIRA, MICHI SAWABE, HOSHINO TERADA, SHINTARO BEPPU, DAISUKE NISHIKAWA, HIDENORI SUZUKI, NOBUHIRO HANAI and KEI MURO
    Anticancer Research March 2024, 44 (3) 1227-1232; DOI: https://doi.org/10.21873/anticanres.16918

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 16
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire